v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 169,728 $ 73,046
Short-term investments 881 32,914
Accounts receivable, net 2,720  
License receivable   1,546
Research and development tax credits receivable 515 316
Prepaid expenses 1,035 1,805
Inventory, net 4,722 648
Other receivables 726 1,646
Total current assets 180,327 111,921
Operating lease right-of-use assets 829 1,129
Property and equipment, net 469 511
Total assets 181,625 113,561
Current liabilities    
Accounts payable 8,454 5,645
Accrued liabilities 11,983 7,644
Operating lease liabilities 670 647
Deferred revenue 1,034  
Other current liabilities 43 43
Total current liabilities 22,184 13,979
Operating lease liabilities, net of current portion 192 539
Senior secured convertible notes 59,207 57,191
Royalty financing obligation, long-term 81,763  
Other long-term liabilities 61 83
Total liabilities 163,407 71,792
Shareholders' Equity    
Common shares, no par value, unlimited shares authorized, 124,497,980 shares issued and outstanding as of June 30, 2026, 106,236,344 shares issued and outstanding as of December 31, 2025 384,985 352,619
Pre-funded warrants - 16,412,925 issued and outstanding as of June 30, 2026, and 16,412,925 as of December 31, 2025 55,649 55,649
Additional paid-in capital 62,867 64,104
Accumulated deficit (485,283) (430,603)
Total shareholders' equity 18,218 41,769
Total liabilities and shareholders' equity $ 181,625 $ 113,561